Prev：MiR-3613-5p targets AQP4 to promote the progression of chronic atrophic gastritis to gastric cancer.(KTA8010-4.800)
Next：A Novel Prognostic Signature Integrating Immune and Glycolytic Pathways for Enhanced Prognosis and Immunotherapy Prediction in Hepatocellular Carcinoma.(KTB1016-3.400)
